NCT00581308View on ClinicalTrials.gov

Long-term Safety Study of the GORE® HELEX® Septal Occluder

NACompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2014

Conditions
Septal Defect, Atrial
Interventions
DEVICE

GORE® HELEX® Septal Occluder

Percutaneous transcatheter closure of ostium secundum atrial septal defects (ASDs)

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT00581308 - Long-term Safety Study of the GORE® HELEX® Septal Occluder | Biotech Hunter | Biotech Hunter